Hummingbird Bioscience Licenses Monoclonal Antibodies To Immunome For Exclusive Worldwide Use, Receives Upfront Payment And Potential Milestone Payments, Royalties

BenzingaJan 7 21:20

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireDec 3, 2024 07:26

Express News | Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 3, 2024 07:26

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 27, 2024 21:00

Immunome President Acquires 24% More Stock

Simply Wall StNov 27, 2024 18:19

Immunome Insider Bought Shares Worth $962,181, According to a Recent SEC Filing

MT NewswiresNov 25, 2024 22:05